Patents by Inventor Philippe Stock

Philippe Stock has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160136204
    Abstract: A unique CD4+CD25+ regulatory T cell population develops from naive CD4+CD25? T cells during a TH1 polarized immune response (called TH1-TR cells). These TH1-TR cells can be generated by contacting naïve T cells with mature CD8?+ dendritic cells (DCs) that have been exposed to a TH1 polarizing adjuvant and, in some cases, an antigen of interest. The TH1-TR are identified by their expression of the cytokines IL-10 and IFN-?, the transcriptional regulators T-bet and FoxP3, and the cell surface molecules CD4, CD25, CD69, CD44 and ICOS.
    Type: Application
    Filed: September 29, 2015
    Publication date: May 19, 2016
    Inventors: Dale Umetsu, Rosemarie Dekruyff, Omid Akbari, Philippe Stock
  • Publication number: 20080241174
    Abstract: A unique CD4+CD25+ regulatory T cell population develops from naive CD4+CD25? T cells during a TH1 polarized immune response (called TH1-TR cells). These TH1-TR cells can be generated by contacting naïve T cells with mature CD8?+ dendritic cells (DCs) that have been exposed to a TH1 polarizing adjuvant and, in some cases, an antigen of interest. The TH1-TR are identified by their expression of the cytokines IL-10 and IFN-?, the transcriptional regulators T-bet and FoxP3, and the cell surface molecules CD4, CD25, CD69, CD44 and ICOS.
    Type: Application
    Filed: March 18, 2005
    Publication date: October 2, 2008
    Applicant: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Dale Umetsu, Rosemarie Dekruyff, Omid Akbari, Philippe Stock